MIA Reports

The FDA recently approved lumateperone for schizophrenia. A review of the clinical trials reveals a testing process that is fatally flawed, and a new drug coming to market that doesn't provide a clinically meaningful benefit.

The poster-children of psychiatric genetics, who endured abuse throughout their lives, were also the product of a racist culture.

MIA’s Justin Karter interviews humanistic-existential psychologist Kirk Schneider about how psychology can play a role in confronting the political, social, and climate crises facing humankind.

Hanna Pickard on the elusive middle ground between personal responsibility and systemic factors in our understandings of addiction.

Two National Empowerment Center leaders discuss eCPR, a process for helping youth—or anyone—through an emotional crisis using three simple steps.

MIA’s Ayurdhi Dhar interviews Diana Kopua about the Mahi a Atua approach, the global mental health movement, and the importance of language and narratives in how we understand our world and ease our suffering.

Dr. Raskin discusses psychotherapists’ dissatisfaction with current psychiatric diagnostic systems and explores alternatives.

Morgan Shields discussed her experiences in inpatient psychiatry and her efforts to bring patient-centered care to this oft-neglected field.

MIA's Richard Sears interviews psychotherapist Anne Guy about working with clients withdrawing from psychiatric drugs.

James Greenblatt is an innovator and longtime authority in the fields of integrative medicine and functional psychiatry, focusing on nutrition and other natural modes...

A maternal mental health expert shares how perinatal stress and the climate crisis are affecting women’s everyday lives.

MIA’s Micah Ingle interviews Mary Watkins about reorienting psychology toward liberation and social justice.

Father and daughter Ken and Alice Thompson run the Visible Hands Collaborative, bringing Integrative Community Therapy to the US.

Ayurdhi Dhar interviews Nandita Chaudhary about children’s lives across cultures, the problems with global aid agencies and their interventions, psychology’s bias in the study of children, the limits of attachment theory and more.

MIA’s Justin Karter interviews psychiatrist Awais Aftab about how “conceptual competence” uses philosophy to transform psychiatry.

In an interview with MIA's Akansha Vaswani, narrative therapist Jennifer Freeman calls for a shift away from individualistic approaches to 'eco-anxiety' and toward responses that connect us all to a counter-tsunami of action for the planet.

After Joanna Moncrieff and colleagues published their study debunking the low-serotonin theory of depression, the editor of Mad in Sweden, Lasse Mattila, wrote Sweden’s...

In his book "What is Health," Peter Sterling asks this provocative question: What does our species require for a healthy life? And can we achieve this with drugs?

Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.

Drug safety advocate David Carmichael joins us to discuss his upcoming antidepressant safety tour and the importance of fully informed consent when prescribing SSRI antidepressants.

Harrow's research over the years told of how long-term antipsychotic use is associated with worse outcomes, even after controlling for psychosis severity.

A survey of 233,087 “internet users” in 34 countries that measured “mental wellbeing” found that the percentage of respondents who were “distressed or struggling” was highest in English-speaking regions of the world, where 30% fell into this category.

Author William Styron is often remembered for speaking about depression as an illness. But a review of his life reveals that psychiatric drugs may have triggered and even worsened his depressive episodes.

Hallucinogen Persisting Perception Disorder (HPPD) is one of the after-effects neglected amid the rapid march of the psychedelic renaissance. But is the impulse to pathologise these perceptual changes helpful?

Ayurdhi Dhar interviews sociologist Owen Whooley about psychiatry's stubborn perseverance in the face of recent DSM embarrassments and the failures of the biomedical model.